If you sell Greencross Limited now, you might regret it

Have Greencross Limited (ASX:GXL) shares got further to run?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Many readers will be familiar with the vet and pet store brand that has grown considerably in recent years. Yet despite all the growth, I think investors would be doing themselves a disservice by selling their shares in Greencross Limited (ASX: GXL) now. Here's why:

  • The company is self-funding its growth

Unlike in recent years, Greencross is now generating 'free cash flow' which means that it generates leftover cash after its expenses are paid. In previous years, the company was running at a deficit, and funding its operations via debt.

In previous years, you could have reasonably decided that expanding via debt was too risky. That is no longer the case.

  • It has a long way to go before reaching its stores' full potential

Greencross is co-locating its vet and pet grooming services into its retail stores. Company figures show that this both makes them cheaper to establish and improves retail sales. However, only 10% of Greencross stores have a vet, and 31% have a groomer.

There is plenty of room for the company to grow its sales by rolling out more vet and grooming services. Stores and vet clinics also take a couple of years to reach maturity, which means that recent openings should continue to deliver 'like for like' sales growth. On top of that, Greencross only controls around 6% of the total Australian pet market.

  • Many ways to grow

The potential of some other initiatives like loyalty cards, online sales, pet insurance, and private label products should not be overlooked. With 237 retail stores and 164 vets, Greencross is also small enough that it can continue to grow via acquisition, even at a slow rate.

Although the company's share price hasn't been very exciting over the past two years, Greencross has made plenty of progress and I think it would be a mistake to sell the company now.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia owns shares of Greencross Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »